Samsara BioCapital’s Surrozen Inc Warrant SRZNW Stock Holding History

Samsara BioCapital’s Portfolio SRZNW Stock Details SRZNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-99,999	Closed	-$1.78K	–	27
2025 Q3	$1.78K	Hold	99,999	–	–	﹤0.01%	27
2025 Q2	$1.81K	Hold	99,999	–	–	﹤0.01%	29
2025 Q1	$3K	Hold	99,999	–	–	﹤0.01%	37
2024 Q4	$2.14K	Hold	99,999	–	–	﹤0.01%	43
2024 Q3	$1.03K	Hold	99,999	–	–	﹤0.01%	42
2024 Q2	$1.66K	Hold	99,999	–	–	﹤0.01%	40
2024 Q1	$3.02K	Hold	99,999	–	–	﹤0.01%	39
2023 Q4	$1.94K	Hold	99,999	–	–	﹤0.01%	41
2023 Q3	$4.11K	Hold	99,999	–	–	﹤0.01%	41
2023 Q2	$5.52K	Hold	99,999	–	–	﹤0.01%	47
2023 Q1	$10K	Hold	99,999	–	–	﹤0.01%	56
2022 Q4	$5.51K	Hold	99,999	–	–	﹤0.01%	55
2022 Q3	$18K	Hold	99,999	–	–	﹤0.01%	56
2022 Q2	$19K	Buy	+99,999	New	+$22.5K	0.01%	57

Other funds holding SRZNW

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

SCP

SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

ROTUOC

Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return

Samsara BioCapital's SRZNW Position: Q4 2025 in Review

Samsara BioCapital sold out of Surrozen Inc Warrant (SRZNW) in Q4 2025, closing a stake of 99,999 shares — an estimated $1.78K sold.

Samsara BioCapital first reported a position in SRZNW in Q2 2022 and held it in 14 quarters. The position peaked at $19K in Q2 2022. 16 funds tracked by Wall St. Rank hold SRZNW as of Q4 2025.

Samsara BioCapital reported no remaining Surrozen Inc Warrant position as of Q4 2025 after selling out during the quarter.
Samsara BioCapital sold 99,999 Surrozen Inc Warrant shares in Q4 2025, an estimated $1.78K.
Samsara BioCapital first reported a position in Surrozen Inc Warrant in Q2 2022 and held it in 14 quarters.
Samsara BioCapital's Surrozen Inc Warrant position peaked at $19K in Q2 2022.
16 funds tracked by Wall St. Rank held Surrozen Inc Warrant as of Q4 2025.

Based on Samsara BioCapital's 13F filing for Q4 2025, filed 17 Feb 2026.